Article Information
History
- April 9, 2020.
Article Versions
- You are currently viewing Version 1 of this article (April 9, 2020 - 12:54).
- Version 2 (May 19, 2020 - 01:21).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Institute of TCM Clinical Basic Medicine, School of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China
- 2Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China
- 3Key Laboratory of Medical Neurobiology of National Health Commission and Chinese Academy of Medical Sciences, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China
- ↵*Corresponding Author: Chengping Wen, PhD, MD. Binwen Road 548, Hangzhou, Zhejiang, China, tel & fax: +86-571-86613587, e-mail: wengcp{at}163.com, Zhenghao Xu, PhD. Binwen Road 548, Hangzhou, Zhejiang, China, tel & fax: +86-571-86613587, e-mail: xuzhenghao{at}zcmu.edu.cn
The first three author contribute equally.
Posted April 09, 2020.
The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in human and mouse brain
